Literature DB >> 8621950

Application of experimental design techniques to optimize a competitive ELISA.

G S Sittampalam1, W C Smith, T W Miyakawa, D R Smith, C McMorris.   

Abstract

This paper describes the application of experimental design techniques to optimize a sensitive ELISA for a hapten molecule with a calibration range of 0-1000 pg/ml. Ten factors that were expected to affect the assay performance were initially screened, followed by factorial experiments to delineate the effects of the critical factors identified at the screening stage. Assay performance was evaluated using a unique rating system based on standard curve reproducibility, assay detection limits and the use of desirability functions. This rating system allowed multiple responses to be evaluated simultaneously. It was found that the substrate incubation time and enzyme label lot played an important role, while dilutions of the enzyme label and the anti-hapten antibody showed significant interaction. These observations were in good agreement with optimal assay conditions based on historical data collected over a period of two to three years. Application of experimental design techniques enabled us to confirm the significance of the factors affecting the assay within a three month period, with a minimum number of experiments. In addition, information on interaction between factors were determined.

Mesh:

Substances:

Year:  1996        PMID: 8621950     DOI: 10.1016/0022-1759(95)00262-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Ligand binding assays in the 21st Century laboratory: automation.

Authors:  Ago B Ahene; Chris Morrow; David Rusnak; Susan Spitz; Joel Usansky; Holger Pils; Francesca Civoli; Kinnari Pandya; Brian Sue; Daniel Leach; John Derent
Journal:  AAPS J       Date:  2012-03       Impact factor: 4.009

Review 2.  Design of Experiments As a Tool for Optimization in Recombinant Protein Biotechnology: From Constructs to Crystals.

Authors:  Christos Papaneophytou
Journal:  Mol Biotechnol       Date:  2019-12       Impact factor: 2.695

Review 3.  Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments.

Authors:  Jonathan Peter; Clare Green; Michael Hoelscher; Peter Mwaba; Alimuddin Zumla; Keertan Dheda
Journal:  Curr Opin Pulm Med       Date:  2010-05       Impact factor: 3.155

4.  Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.

Authors:  Keertan Dheda; Virginia Davids; Laura Lenders; Teri Roberts; Richard Meldau; Daphne Ling; Laurence Brunet; Richard van Zyl Smit; Jonathan Peter; Clare Green; Motasim Badri; Leonardo Sechi; Surendra Sharma; Michael Hoelscher; Rodney Dawson; Andrew Whitelaw; Jonathan Blackburn; Madhukar Pai; Alimuddin Zumla
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

5.  A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid.

Authors:  Kelly A N Messingham; Megan H Noe; Marisa A Chapman; George J Giudice; Janet A Fairley
Journal:  J Immunol Methods       Date:  2009-05-05       Impact factor: 2.303

6.  An ELISA-based procedure for assaying proteins in digests of human leukocytes and cell lines, using specifically selected peptides and appropriate antibodies.

Authors:  Ori Braitbard; Janette Bishara-Shieban; Hava Glickstein; Miriam Kott-Gutkowski; Umberto Pace; Deborah G Rund; Wilfred D Stein
Journal:  Proteome Sci       Date:  2006-06-21       Impact factor: 2.480

7.  Evaluating concentration estimation errors in ELISA microarray experiments.

Authors:  Don Simone Daly; Amanda M White; Susan M Varnum; Kevin K Anderson; Richard C Zangar
Journal:  BMC Bioinformatics       Date:  2005-01-26       Impact factor: 3.169

8.  Rapid multiple immunoenzyme assay of mycotoxins.

Authors:  Alexandr E Urusov; Anatoly V Zherdev; Alina V Petrakova; Elchin G Sadykhov; Olga V Koroleva; Boris B Dzantiev
Journal:  Toxins (Basel)       Date:  2015-01-27       Impact factor: 4.546

9.  Rapid immunoenzyme assay of aflatoxin B1 using magnetic nanoparticles.

Authors:  Alexandr E Urusov; Alina V Petrakova; Maxim V Vozniak; Anatoly V Zherdev; Boris B Dzantiev
Journal:  Sensors (Basel)       Date:  2014-11-18       Impact factor: 3.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.